RWA
TMO icon

River Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

River Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.66M Sell
3,385
-258
-7% -$140K 0.19% 83
2025
Q4 		$2.11M Sell
3,643
-296
-8% -$167K 0.24% 78
2025
Q3 		$1.91M Sell
3,939
-263
-6% -$122K 0.22% 81
2025
Q2 		$1.7M Sell
4,202
-551
-12% -$230K 0.21% 90
2025
Q1 		$2.37M Sell
4,753
-590
-11% -$320K 0.33% 69
2024
Q4 		$2.78M Sell
5,343
-513
-9% -$282K 0.37% 65
2024
Q3 		$3.62M Sell
5,856
-208
-3% -$123K 0.48% 56
2024
Q2 		$3.35M Sell
6,064
-1,554
-20% -$890K 0.48% 58
2024
Q1 		$4.43M Sell
7,618
-2,089
-22% -$1.17M 0.64% 42
2023
Q4 		$5.15M Sell
9,707
-208
-2% -$101K 0.82% 32
2023
Q3 		$5.02M Buy
9,915
+258
+3% +$137K 0.9% 29
2023
Q2 		$5.04M Buy
9,657
+275
+3% +$148K 0.85% 28
2023
Q1 		$5.41M Buy
9,382
+197
+2% +$111K 0.98% 22
2022
Q4 		$5.06M Buy
9,185
+396
+5% +$210K 0.97% 23
2022
Q3 		$4.46M Sell
8,789
-585
-6% -$327K 0.96% 25
2022
Q2 		$5.09M Buy
9,374
+41
+0.4% +$22.6K 0.94% 25
2022
Q1 		$5.51M Buy
9,333
+812
+10% +$466K 0.88% 28
2021
Q4 		$5.69M Buy
8,521
+59
+0.7% +$36.8K 0.88% 29
2021
Q3 		$4.83M Buy
8,462
+471
+6% +$259K 0.83% 29
2021
Q2 		$4.03M Buy
7,991
+216
+3% +$102K 0.71% 39
2021
Q1 		$3.55M Buy
7,775
+505
+7% +$241K 0.67% 40
2020
Q4 		$3.39M Buy
7,270
+886
+14% +$415K 0.73% 36
2020
Q3 		$2.82M Buy
6,384
+426
+7% +$176K 0.74% 39
2020
Q2 		$2.16M Buy
5,958
+265
+5% +$88.8K 0.66% 47
2020
Q1 		$1.61M Buy
5,693
+162
+3% +$51.1K 0.64% 54
2019
Q4 		$1.8M Buy
5,531
+339
+7% +$103K 0.61% 59
2019
Q3 		$1.51M Sell
5,192
-20
-0.4% -$5.73K 0.57% 62
2019
Q2 		$1.53M Buy
5,212
+126
+2% +$34.7K 0.6% 60
2019
Q1 		$1.39M Sell
5,086
-156
-3% -$38.8K 0.58% 60
2018
Q4 		$1.17M Buy
5,242
+110
+2% +$25.8K 0.52% 62
2018
Q3 		$1.25M Buy
5,132
+95
+2% +$21.9K 0.46% 73
2018
Q2 		$1.04M Buy
5,037
+275
+6% +$58.4K 0.41% 81
2018
Q1 		$983K Sell
4,762
-255
-5% -$53.5K 0.41% 82
2017
Q4 		$953K Buy
5,017
+110
+2% +$21.1K 0.4% 88
2017
Q3 		$928K Buy
4,907
+350
+8% +$63.4K 0.42% 85
2017
Q2 		$795K Buy
4,557
+95
+2% +$16K 0.37% 92
2017
Q1 		$685K Sell
4,462
-255
-5% -$39K 0.33% 96
2016
Q4 		$666K Sell
4,717
-130
-3% -$19.2K 0.34% 94
2016
Q3 		$771K Sell
4,847
-89
-2% -$13.7K 0.43% 81
2016
Q2 		$729K Buy
4,936
+221
+5% +$32.6K 0.42% 85
2016
Q1 		$668K Sell
4,715
-414
-8% -$55.5K 0.4% 87
2015
Q4 		$728K Sell
5,129
-150
-3% -$20K 0.46% 78
2015
Q3 		$646K Sell
5,279
-220
-4% -$28.7K 0.44% 78
2015
Q2 		$714K Sell
5,499
-25
-0.5% -$3.26K 0.45% 79
2015
Q1 		$742K Buy
+5,524
New +$712K 0.46% 77

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

River Wealth Advisors's TMO Position: Q1 2026 in Review

River Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 7.1% in Q1 2026, selling an estimated $140K and leaving 3,385 shares worth $1.66M. The position accounts for 0.19% of the portfolio, ranked #83.

River Wealth Advisors first reported a position in TMO in Q1 2015 and has held it in 45 quarters since. The position peaked at $5.69M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • River Wealth Advisors held 3,385 shares of Thermo Fisher Scientific worth $1.66M as of Q1 2026.
  • River Wealth Advisors sold 258 Thermo Fisher Scientific shares in Q1 2026, an estimated $140K.
  • Thermo Fisher Scientific made up 0.19% of River Wealth Advisors's portfolio in Q1 2026, its #83 holding.
  • River Wealth Advisors first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 45 quarters since.
  • River Wealth Advisors's Thermo Fisher Scientific position peaked at $5.69M in Q4 2021.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on River Wealth Advisors's 13F filing for Q1 2026, filed 13 May 2026.